Leishmaniasis
📧 Sign up to get email alerts when something new happens for Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil [Phase 2]
Phase 2 clinical trial evaluating miltefosine in combination with pentoxifylline for mucosal and cutaneous leishmaniasis in Brazil.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly [Phase 2, Phase 3]
Pilot study evaluating an oral treatment for American tegumentary leishmaniasis (cutaneous and mucosal forms) in elderly participants; curre…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects [Phase 1]
Phase 1 trial update on safety, tolerability, and pharmacokinetics of GSK3186899 in healthy subjects; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis [Phase 2]
Phase 2 trial evaluating topical liposomal amphotericin B gel for cutaneous leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Intralesional Antimony for Bolivian Cutaneous Leishmaniasis [Phase 2]
A Phase 2 clinical trial evaluating intralesional antimony for Bolivian cutaneous leishmaniasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients [Phase 2]
Phase 2 trial evaluating 18-Methoxycoronaridine for efficacy, safety, and tolerability in cutaneous leishmaniasis is underway but status is …
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Use of Sodium Stibogluconate as a Treatment for Leishmaniasis [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating sodium stibogluconate as a treatment for leishmaniasis, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis [Phase 2]
Phase 2 clinical trial update for a fourth-generation Immucillin derivative (DI4G) associated therapy in cutaneous leishmaniasis has complet…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Sodium Stibogluconate Treatment of Leishmaniasis [Phase 2]
A Phase 2 clinical trial evaluating sodium stibogluconate for leishmaniasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine [Phase 1]
This update notes the completion of a Phase 1 trial evaluating LEISH-F3 vaccines with GLA-SE or MPL-SE adjuvants for leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis [Phase 2]
A Phase 2 clinical trial evaluating miltefosine for mucocutaneous leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers [Phase 1]
Phase 1 assessment of the LEISH-F3 vaccine in healthy adult volunteers has been completed, reporting safety and immunogenicity data for leis…
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0) [Phase 2, Phase 3]
Phase 2/3 trial update of a killed Leishmania vaccine tested in healthy volunteers, reporting safety and efficacy assessments with the study…
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Miltefosine for Mucosal Leishmaniasis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating miltefosine for mucosal leishmaniasis has completed.